Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

NCT03597022 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03597022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03597022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Terminated
Start date
July 24, 2018
Completion date
October 15, 2019
Enrollment
24 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a and b